Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline (Q37160367)

18 August 2017

Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline (English)

1 reference

18 August 2017

1 reference

2

Gary E Swan

1 reference

18 August 2017

3

Lisa Jack

1 reference

18 August 2017

1

Jennifer B McClure

1 reference

18 August 2017

4

Sheryl L Catz

1 reference

18 August 2017

5

Susan M Zbikowski

1 reference

18 August 2017

Tim A McAfee

6

1 reference

18 August 2017

Mona Deprey

series ordinal

7

1 reference

18 August 2017

Julie Richards

series ordinal

8

1 reference

18 August 2017

Harold Javitz

series ordinal

9

1 reference

18 August 2017

24 February 2009

1 reference

Journal of General Internal Medicine

18 August 2017

1 reference

18 August 2017

24

1 reference

18 August 2017

5

1 reference

18 August 2017

563-569

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

18 August 2017

start time

24 February 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s11606-009-0926-8

0 references

cites work

Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Varenicline improves mood and cognition during smoking abstinence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Nicotine receptor partial agonists for smoking cessation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Effects of abstinence from tobacco: valid symptoms and time course

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Cigarette smoking and major depression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Perceived stress, quitting smoking, and smoking relapse

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Varenicline treatment for smokers with schizophrenia: a case series.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Signs and symptoms of tobacco withdrawal.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Symptoms of tobacco withdrawal. A replication and extension.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Nicotine dependence, major depression, and anxiety in young adults

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

FDA warns of adverse events linked to smoking cessation drug and antiepileptics

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

A double-blind study evaluating the long-term safety of varenicline for smoking cessation.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2669860

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

3 September 2018

1 reference

12 December 2020

Varenicline-induced manic episode in a patient with bipolar disorder

1 reference

12 December 2020

Exacerbation of schizophrenia by varenicline

1 reference

12 December 2020

Telephone counseling as an adjunct to antidepressant treatment in the primary care system. A pilot study

1 reference

12 December 2020

Smoking cessation and the course of major depression: a follow-up study

1 reference

12 December 2020

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory

1 reference

12 December 2020

Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial

1 reference

12 December 2020

Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers

1 reference

12 December 2020

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

1 reference

12 December 2020

10.1007/S11606-009-0926-8

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference